Patents by Inventor Eugene Morkin

Eugene Morkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
    Patent number: 8399518
    Abstract: Methods and compositions are disclosed for stimulating weight loss and/or lowering triglyceride levels in an individual mammal in need thereof. In an exemplary method, a pharmaceutical composition comprising a therapeutically effective amount of DITPA, and optionally one or more lipid-reducing agents, is administered to an individual mammal to stimulate weight loss, and/or reduce levels of triglyceride and/or lipoprotein in the mammal.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: March 19, 2013
    Assignees: University of Arizona Office of Technology Transfer, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: Eugene Morkin, Louis R. Bucalo, Steven Goldman
  • ADMINISTRATION OF 3,5-DIIODOTHYROPROPIONIC ACID FOR STIMULATING WEIGHT LOSS, AND/OR LOWERING TRIGLYCERIDE LEVELS, AND/OR TREATMENT OF METABOLIC SYNDROME
    Publication number: 20100249235
    Abstract: The invention provides methods and compositions for stimulating weight loss or lowering triglyceride levels in an individual in need thereof. In methods of the invention, a pharmaceutical composition comprising a therapeutically effective amount of DITPA, and optionally one or a plurality of lipid lowering agents, is administered to an individual to stimulate weight loss, lower triglyceride and/or lipoprotein levels, and/or to treat one or more symptoms of metabolic syndrome.
    Type: Application
    Filed: February 27, 2008
    Publication date: September 30, 2010
    Applicants: TITAN PHARMACEUTICALS, INC., THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Eugene Morkin, Louis R. Bucalo, Steven Goldman
  • METHOD FOR STIMULATING WEIGHT LOSS AND/OR FOR LOWERING TRIGLYCERIDES IN PATIENTS
    Publication number: 20090076151
    Abstract: Administration of a therapeutically effective amount of 3,5-diiodothyropropionic acid stimulates weight loss in patients, lowers triglyceride levels and reduces risk of death or progression of coronary heart disease in patients with metabolic syndrome.
    Type: Application
    Filed: November 25, 2008
    Publication date: March 19, 2009
    Inventors: Eugene MORKIN, Cynthia Ruth Adamson, Steven Goldman
  • Method for stimulating weight loss and/or for lowering triglycerides in patients
    Patent number: 7504435
    Abstract: Administration of a therapeutically effective amount of 3,5-diiodothyropropionic acid stimulates weight loss in patients, lowers triglyceride levels and reduces risk of death or progression of coronary heart disease in patients with metabolic syndrome.
    Type: Grant
    Filed: April 13, 2005
    Date of Patent: March 17, 2009
    Assignee: The Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Cynthia R. Adamson, legal representative, Steven Goldman, Eugene Morkin
  • Method for stimulating weight loss and/or for lowering triglycerides in patients
    Publication number: 20080146668
    Abstract: Administration of a therapeutically effective amount of 3,5-diiodothyropropionic acid stimulates weight loss in patients, lowers triglyceride levels and reduces risk of death or progression of coronary heart disease in patients with metabolic syndrome.
    Type: Application
    Filed: April 13, 2005
    Publication date: June 19, 2008
    Inventor: Eugene Morkin
  • Method to treat chronic heart failure and/or elevated cholesterol levels
    Publication number: 20050159490
    Abstract: A method for treating a patient having congestive heart failure by administering a therapeutically effective amount of a thyroid hormone analog sufficient to produce an increase in cardiac index of at least 15% while increasing heart rate no more than 10 beats per minute.
    Type: Application
    Filed: April 5, 2004
    Publication date: July 21, 2005
    Inventor: Eugene Morkin
  • Method to treat chronic heart failure and/or elevated cholesterol levels
    Patent number: 6716877
    Abstract: A method for treating a patient having congestive heart failure by administering a therapeutically effective amount of 3′,3,5-triiodothyropropionic acid (TRIPROP) or 3,5,3′,5′-tetraiodothyropropionic acid (TETRAPROP). Also described is a method to lower cholesterol blood levels of a patient by administering a therapeutically effective amounts of TRIPROP or TETRAPROP.
    Type: Grant
    Filed: February 18, 2003
    Date of Patent: April 6, 2004
    Assignee: The Arizona Board of Regents on behalf of the University of Arizona
    Inventor: Eugene Morkin
  • Method to treat chronic heart failure and/or elevated cholesterol levels
    Publication number: 20030147815
    Abstract: A method for treating a patient having congestive heart failure by administering a therapeutically effective amount of 3′,3,5-triiodothyropropionic acid (TRIPROP) or 3,5,3′,5′-tetraiodothyropropionic acid (TETRAPROP). Also described is a method to lower cholesterol blood levels of a patient by administering a therapeutically effective amounts of TRIPROP or TETRAPROP.
    Type: Application
    Filed: February 18, 2003
    Publication date: August 7, 2003
    Inventor: Eugene Morkin
  • Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
    Patent number: 6534676
    Abstract: Applicants' invention includes a method to treat a patient having congestive heartfailure by administering a therapeutically effective amount of 3,5-diidothyropropionic acid. Applicants' invention further includes a method to lower cholesterol blood levels of a patient by administering a therapeutically effective amount of 3,5-diidothyropropionic acid. Applicants' invention further includes a synthetic method to prepare 3,5-diidothyropropionic acid.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: March 18, 2003
    Assignees: The Arizona Board of Regents on Behalf of the University of Arizona, Southern Arizona Veterans Affairs Health Care System
    Inventors: Eugene Morkin, Gregory D. Pennock, Joseph J. Bahl, Steven Goldman
  • Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
    Publication number: 20020151594
    Abstract: Applicants' invention includes a method to treat a patient having congestive heart failure by administering a therapeutically effective amount of 3,5-diidothyropropionic acid. Applicants' invention further includes a method to lower cholesterol blood levels of a patient by administering a therapeutically effective amount of 3,5-diidothyropropionic acid. Applicants' invention further includes a synthetic method to prepare 3,5-diidothyropropionic acid.
    Type: Application
    Filed: January 31, 2001
    Publication date: October 17, 2002
    Applicant: Arizona Board of Regents on Behalf of The University of Arizona
    Inventors: Eugene Morkin, Gregory D. Pennock, Joseph J. Bahl, Steven Goldman